Taken together, these results indicate that NANEP5T141A/R147A is a handicapped repressor in vivo and in vitro, and suggest that the superb in vivo phenotype observed with NANEP5 in GBM cells in which it is made in a stable manner is due to the repression of NANOG targets. The gene discussed is NANOG; the disease is glioblastoma.